[HTML][HTML] Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
…, C Coudon, J Esnault, T Guimard… - The Lancet …, 2021 - thelancet.com
Background Elevated proinflammatory cytokines are associated with greater COVID-19 severity.
We aimed to assess safety and efficacy of sarilumab, an interleukin-6 receptor inhibitor, …
We aimed to assess safety and efficacy of sarilumab, an interleukin-6 receptor inhibitor, …
No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception
…, T Guimard, K Guimard… - Clinical Infectious …, 2015 - academic.oup.com
Background. The efficacy of preventing perinatal transmission (PT) of human immunodeficiency
virus type 1 (HIV-1) depends on both viral load (VL) and treatment duration. The …
virus type 1 (HIV-1) depends on both viral load (VL) and treatment duration. The …
[HTML][HTML] Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial
…, E Devaud, O Robineau, P Rispal, T Guimard… - Clinical Microbiology …, 2021 - Elsevier
Objectives To determine whether hydroxychloroquine decreases the risk of adverse outcome
in patients with mild to moderate coronavirus disease 2019 (COVID-19) at high risk of …
in patients with mild to moderate coronavirus disease 2019 (COVID-19) at high risk of …
Increased risk of serious bacterial infections due to maternal immunosuppression in HIV-exposed uninfected infants in a European country
…, T Guimard, K Guimard… - Clinical Infectious …, 2014 - academic.oup.com
Background. Morbidity and mortality are higher among human immunodeficiency virus (HIV)
exposed but uninfected (HEU) infants than unexposed infants, particularly if the mother had …
exposed but uninfected (HEU) infants than unexposed infants, particularly if the mother had …
Impact of Enterococcus faecalis Endocarditis Treatment on Risk of Relapse
…, JP Talarmin, R Buzelé, T Guimard… - Clinical Infectious …, 2023 - academic.oup.com
Background Enterococcus faecalis infective endocarditis (EFIE) is characterized by a higher
frequency of relapses than other infective endocarditis. The role of the treatment on its …
frequency of relapses than other infective endocarditis. The role of the treatment on its …
[HTML][HTML] Incidence, characteristics, and mortality of infective endocarditis in France in 2011
…, D Boutoille, P Tattevin, E Denes, T Guimard… - PLoS …, 2019 - journals.plos.org
Objectives We assessed the determinants of mortality in infective endocarditis (IE), using
the national hospital discharge databases (HDD) in 2011. Methods IE stays were extracted …
the national hospital discharge databases (HDD) in 2011. Methods IE stays were extracted …
[HTML][HTML] Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability and determinants of outcome in a multicentre prospective cohort
…, C Gubavu, I Gueit, D Guelon, T Guimard… - Clinical Microbiology …, 2020 - Elsevier
Objectives To identify factors associated with unfavourable in-hospital outcome (death or
disability) in adults with community-acquired bacterial meningitis (CABM). Methods In a …
disability) in adults with community-acquired bacterial meningitis (CABM). Methods In a …
Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID‐19 patients
…, G COLIN, R DECOURS, T GUIMARD… - Journal of Medical …, 2021 - Wiley Online Library
Little is known on the association between clinical factors and coronavirus disease 2019 (COVID‐19)
more than 15 days after diagnosis. We conducted a multicentric prospective cohort …
more than 15 days after diagnosis. We conducted a multicentric prospective cohort …
[HTML][HTML] Efficacy and safety of anakinra in adults presenting deteriorating respiratory symptoms from COVID-19: A randomized controlled trial
…, R Goulabchand, L Colombain, A Bigot, T Guimard… - PLoS …, 2022 - journals.plos.org
Objective We aimed to investigate whether anakinra, an interleukin-1receptor inhibitor,
could improve outcome in moderate COVID-19 patients. Methods In this controlled, open-label …
could improve outcome in moderate COVID-19 patients. Methods In this controlled, open-label …
In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial
…, T Guimard, K Guimard… - Clinical Infectious …, 2015 - academic.oup.com
Background. Antiretroviral (ARV) regimens during pregnancy are highly effective in preventing
mother-to-child transmission of human immunodeficiency virus (HIV). Congenital heart …
mother-to-child transmission of human immunodeficiency virus (HIV). Congenital heart …